Florida, February 06.2018: The scope of the report includes a detailed study of global and regional markets for Global Q-PCR and D-PCR Devices Market with the reasons given for variations in the growth of the industry in certain regions.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, Agilent Technologies Inc. Analytik Jena AG, Becton, Dickinson and Company, Bio-Rad Laboratories Inc. Biome me Inc. Biomérieux S.A., Bioneer Corporation, Biosystemika Research and, Development LLC, Danaher Corporation, Denville Scientific Inc., Elitech Group, Enzo Life Science Inc. Eppendorf AG,F. Hoffmann-La Roche Ltd. Fluidigm Corporation, Formulatrix Inc., JnMedsys, Merck KGaA, Meridian Bioscience Inc., Promega Corporation, Qiagen N.V., Quanta, Biosciences Inc., Takara Bio Inc. Thermo Fisher Scientific Inc. among others. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    The is Global Q-PCR and D-PCR Devices Market expected to exceed more than US$ 4.96 Billion by 2022 at a CAGR of 8.9% in the given forecast period.

    You can browse full report: https://www.marketresearchengine.com/qpcr-and-dpcr-devices-market

    This report provides:

    1) An overview of the global market for Global Q-PCR and D-PCR Devices Market and related technologies.
    2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
    3) Identifications of new market opportunities and targeted promotional plans for Global Q-PCR and D-PCR Devices Market.
    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry.

    The major driving factors of Global Q-PCR and D-PCR Devices Market are as follows:

    • Rising Incidences of Infectious Diseases and Genetic Disorders
    • Technological Advancement in PCR Technologies
    • Growth in Public-Private Funds, Investments and Grants
    • Growing Use of Biomarker Profiling for Disease Diagnostics
    • Successful Completion of the Human Genome Project

    The restraining factors of Global Q-PCR and D-PCR Devices Market are as follows:

    • High Device Costs Associated With dPCR.
    • Adoption and Implementation of Miqe Guidelines for Publishing
    • Technical Limitations of qPCR and dPCR Techniques.

    Request Sample Report: https://www.marketresearchengine.com/qpcr-and-dpcr-devices-market

    Table of Contents


    2 Research Methodology

    3 Executive Summary

    4 Premium Insights

    5 Market Overview

    6 Industry Trends

    7 Global qPCR and dPCR Market, By Technology

    8 Global qPCR and dPCR Market, By Product and Service

    9 qPCR and dPCR Market, By Application

    10 qPCR and dPCR Market, By End User

    11 qPCR and dPCR Market, By Region

    12 Competitive Landscape

    13 Company Profiles

    13.1 Introduction

    13.2 F. Hoffman-La Roche Ltd.

    13.3 Thermo Fisher Scientific, Inc.

    13.4 Bio-Rad Laboratories, Inc.

    13.5 Qiagen N.V.

    13.6 Takara Bio, Inc.

    13.7 Agilent Technologies, Inc.

    13.8 Biomérieux S.A.

    13.9 Fluidigm Corporation

    13.10 Danaher Corporation

    13.11 ABBott Laboratories

    13.12 Merck KGaA

    13.13 Becton Dickinson and Company

    13.14 Promega Corporation

    13.15 Meridian Bioscience, Inc. (Bioline Reagents Ltd.)

    13.16 Analytik Jena AG (Endress+Hauser Ag)

    Media Contact

    Company Name: Market Research Engine

    Contact Person: John Bay

    Email: john@marketresearchengine.com

    Phone: +1-855-984-1862

    Country: United States

    Website: https://www.marketresearchengine.com/



    Source: http://www.financeswire.com/global-q-pcr-and-d-pcr-devices-market-share-will-increase-more-than-us-4-50-billion-by-2024